Effects of Growth Hormone on Bone

Area of Science:

• Endocrinology
• Skeletal Physiology
• Bone Metabolism

Background:

• The growth hormone (GH) and insulin-like growth factor 1 (IGF-1) axis plays a critical role in skeletal development and maintenance.
• Dysregulation of this axis can lead to significant skeletal abnormalities.

Purpose of the Study:

• To elucidate the multifaceted effects of GH and IGF-1 on skeletal physiology.
• To review the therapeutic implications of GH in deficiency and insensitivity states.

Main Methods:

• Literature review of studies investigating GH and IGF-1 effects on bone formation and resorption.
• Analysis of clinical outcomes in patients with GH deficiency, GH excess (acromegaly), and GH insensitivity syndromes.

Main Results:

• GH deficiency is linked to reduced bone turnover, impaired growth, low bone mass, and increased fracture risk.
• GH replacement therapy in children and adults improves bone mineral density (BMD) and may reduce fracture risk.
• Acromegaly is associated with altered bone turnover and potentially decreased BMD, alongside an increased risk of vertebral fractures, especially with hypogonadism.
• GH therapy benefits statural growth in conditions like Turner syndrome, Prader-Willi syndrome, and idiopathic short stature.

Conclusions:

• GH and IGF-1 are vital for normal skeletal physiology.
• GH therapy demonstrates significant therapeutic value in managing skeletal complications of GH deficiency and insensitivity.